1. Home
  2. Labeler Index
  3. Teva Pharmaceuticals Usa, Inc.
  4. 0093-1005
  5. NDC Package Code: 0093-1005-05 Naproxen

NDC Package 0093-1005-05 Naproxen

Tablet, Delayed Release Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0093-1005-05
Package Description:
500 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code:
0093-1005
Proprietary Name:
Naproxen
Non-Proprietary Name:
Naproxen
Substance Name:
Naproxen
Usage Information:
See also Warning section. Naproxen is used to relieve pain from various conditions such as headache, muscle aches, tendonitis, dental pain, and menstrual cramps. It also reduces pain, swelling, and joint stiffness caused by arthritis, bursitis, and gout attacks. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.
11-Digit NDC Billing Format:
00093100505
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
500 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 311915 - naproxen 500 MG Delayed Release Oral Tablet
  • RxCUI: 311915 - naproxen (as naproxen sodium) 500 MG Delayed Release Oral Tablet
  • RxCUI: 603103 - naproxen 375 MG Delayed Release Oral Tablet
  • RxCUI: 603103 - naproxen 375 MG (as naproxen sodium 413 MG) Delayed Release Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Teva Pharmaceuticals Usa, Inc.
    Dosage Form:
    Tablet, Delayed Release - A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • NAPROXEN 375 mg/1
    • Pharmacologic Class(es):
  • Anti-Inflammatory Agents, Non-Steroidal - [CS]
  • Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
  • Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA075227
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    07-31-1998
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0093-1005-01100 TABLET, DELAYED RELEASE in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0093-1005-05?

    The NDC Packaged Code 0093-1005-05 is assigned to a package of 500 tablet, delayed release in 1 bottle of Naproxen, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is tablet, delayed release and is administered via oral form.

    Is NDC 0093-1005 included in the NDC Directory?

    Yes, Naproxen with product code 0093-1005 is active and included in the NDC Directory. The product was first marketed by Teva Pharmaceuticals Usa, Inc. on July 31, 1998 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0093-1005-05?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 500.

    What is the 11-digit format for NDC 0093-1005-05?

    The 11-digit format is 00093100505. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20093-1005-055-4-200093-1005-05